Hero image with Pittsburgh background https://pittplusme.org/study/1205

We're sorry. This study is closed and no longer recruiting participants.

STUDY BASICS

Have you been diagnosed with osteogenesis imperfecta (OI)? If so, you may be eligible to participate in a study to help researchers learn the best dosage of a study drug to treat OI. Includes a pre-screening visit where your blood will be drawn and tested to be sure that you have the specific genetic mutation needed to be eligible for the full study.


IRB: 201704528
- A Phase 2b, Multicentre, Multinational, Placebo-controlled, Double-Blind, Dose-finding Study in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with BPS804

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/1205 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe